Skip to content

Clinical trials

Thyroid Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thyroid Neoplasms Country / region: United Kingdom Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20072
20083
20091
20112
20122
20141
20152
20162
20175
20181
20191
20211
20234
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Active, not recruiting6
Recruiting5
Unknown status2
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Royal Marsden NHS Foundation Trust4
Eisai Inc.3
Eli Lilly and Company2
Exelixis2
Pfizer2
Apollomics Inc.1
Bayer1
Erasca, Inc.1
European Organisation for Research and Treatment of Cancer - EORTC1
Genmab1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thyroid Neoplasms32
Carcinoma, Non-Small-Cell Lung9
Lung Neoplasms7
Carcinoma, Medullary6
Head and Neck Neoplasms6
Colonic Neoplasms5
Neoplasms5
Thyroid Cancer, Papillary5
Thyroid Diseases5
Breast Neoplasms4

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.